Rezolute Inc
7 nominees · 5 ballot items.
Five proposals are on the ballot: (1) election of directors, (2) ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending June 30, 2026, (3) Say-on-Pay advisory vote on named executive officer compensation, (4) amendment to the 2021 Equity Incentive Plan increasing authorized shares, and (5) adjournment of the meeting to solicit additional proxies.
Follow how the vote landed and what changed on Rezolute Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Directors
ManagementBoard: FORElection of seven director-nominees to the Company’s Board of Directors to serve until the 2027 Annual Meeting.
- 2
Accountant Proposal
ManagementBoard: FORRatify Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
- 3
Say-On-Pay Proposal
ManagementBoard: FORAdvisory approval of compensation of the named executive officers as disclosed in the Executive Compensation section of this Proxy Statement.
- 4
Amendment of 2021 Equity Incentive Plan
ManagementBoard: FORIncrease the number of shares available under the 2021 Equity Incentive Plan from 14,450,000 to 21,950,000 shares.
- 5
Adjournment Proposal
ManagementBoard: FORAuthorize the adjournment of the Annual Meeting to solicit additional proxies if there are not sufficient votes in favor of the 2021 Equity Plan Amendment Proposal.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FEDERATED HERMES, INC. | 13.5% | 12,990,659 | $40M |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.5% | 9,180,000 | $28M |
| 3 | Opaleye Management Inc. | 6.5% | 6,300,000 | $19M |
| 4 | BALYASNY ASSET MANAGEMENT L.P. | 5.2% | 5,048,421 | $15M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 3,522,080 | $11M |
| 6 | JENNISON ASSOCIATES LLC | 3.6% | 3,438,881 | $10M |
| 7 | Siren, L.L.C. | 3.5% | 3,328,287 | $10M |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.1% | 2,981,765 | $9M |
| 9 | BANK OF AMERICA CORP /DE/ | 3.0% | 2,904,405 | $9M |
| 10 | BlackRock, Inc. | 2.9% | 2,808,421 | $9M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Rezolute Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Rezolute Inc 2025 annual meeting?
- Rezolute Inc (RZLT) holds its 2025 annual shareholder meeting on Wednesday, November 19, 2025.
- What is the record date for the Rezolute Inc 2025 meeting?
- The record date for the Rezolute Inc 2025 meeting is Monday, September 22, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Rezolute Inc's 2025 meeting?
- The board is presenting 7 director nominees at the Rezolute Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Rezolute Inc 2025 meeting?
- Shareholders will vote on 5 proposals at the Rezolute Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.